IDSA and NIH/CDC guidelines recommend consideration of prophylaxis during a histoplasmosis outbreak or in settings in which the disease incidence is >10 cases per 100 patient-years for persons with CD4 <150/μL [46,67]. The gene discussed is CD4; the disease is histoplasmosis.